Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours

Virchows Archiv

Volumn 429, Issue 4-5, 1996, Pages 213-219

  Miettinen, Markku ^a   Kärkkäinen, Päivi ^b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

CD15; HBME 1; Immunohistochemistry; Thyroid; Tumour

Indexed keywords

CD15 ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ANAPLASTIC CARCINOMA; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FETUS; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID TUMOR; TUMOR CELL;

ADENOCARCINOMA, FOLLICULAR; ANTIBODIES, MONOCLONAL; ANTIGENS, CD15; CARCINOMA; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETUS; GOITER; HUMANS; PREGNANCY; THYROID DISEASES; THYROID NEOPLASMS; THYROIDITIS;

EID: 0029801350     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Arber DA, Weiss LM (1993) CD15. A review. Appl Immunohistochem 1:17-30
2. Carangiu ML, Zampi G, Rosai J (1985) Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Pathol Annu 20:1-44
3. Cordon-Cardo C, Reuter VE, Lloyd KO, et al (1988) Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX and LeY determinants in urothelial carcinomas. Cancer Res 48:4113-4120
4. Damjanov I (1987) Lectin cytochemistry and histochemistry. Lab Invest 57:5-20
5. Dorfman RF, Gatter KC, Pulford KAF, Mason DY (1986) An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Pathol 123:508-519
6. Franssila KO, Ackerman LV, Brown CL, Hedinger CE (1985) Follicular carcinoma. Semin Diagn Pathol 2:101-122
7. Frierson HF, Innes DJ (1985) Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease. Arch Pathol Lab Med 109:1024-1028
8. Gonzalez-Campora R, Sanchez Gallego F, Martin Lacave I, et al (1988) Lectin histochemistry of the thyroid gland. Cancer 62:2354-2362
9. Hakomori SI (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257-331
10. Hakomori SI, Nudelman E, Kannagi R, Levery SB (1982) The common structure in fucosyllactosaminolipids accumulating in human adenocarcinomas, and its possible absence in normal tissue. Biochem Biophys Res Commun 109:36-44
11. Hall PA, D'Ardenne AJ (1987) Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J Clin Pathol 40:1298-1304
12. HSU SM, Yang K, Jaffe ES (1985) Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 118:209-217
13. Kim YS, Itzkowitz SH (1988) Carbohydrate antigen expression in the adenoma-carcinoma sequence. Prog Clin Biol Res 279:241-250
14. Kornstein MJ, Bonner H, Gee B, Cohen R, Brooks JJ (1986) LeuM1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas. Am J Clin Pathol 85:433-437
15. Kotani T, Asada Y, Aratake Y, et al (1992) Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours. J Pathol (Lond) 168:41-45
16. Kukkonen ST, Haapiainen RT, Franssila KO, Sivula A (1990) Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg 148:837-841
17. Langle F, Soliman T, Neuhold N, et al (1994) CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study group on multiple endocrine neoplasia of Austria. World J Surg 18:583-587
18. LeBrun DP, Kamel OW, Dorfman RF, Warnke RA (1992) Enhanced staining for Leu M1 (CD15) in Hodgkin's disease using a secondary antibody for immunoglobulin M. Am J Clin Pathol 97:135-138
19. Livolsi VA (1986) Pathology of the thyroid. Major problems in surgical pathology. Saunders, Philadelphia
20. Miettinen M, Kovatich AJ (1995) HBME-1 monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma and soft tissue and bone tumors. Appl Immunohistochem 3:115-122
21. Neuhold N, Langle F, Gannt M, Hollenstein U, Niederle B (1992) Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinomas. J Cancer Res Clin Oncol 118:629-634
22. Ordonez NG (1989) The immunohistochemical diagnosis of malignant mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 13:276-291
23. Otis CN, Carter D, Cole S, Battifora H (1987) Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol 11:445-456
24. Pinkus GS, Thomas P, Said JW (1985) Leu-M1 - a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 119:244-252
25. Rao SK, Fraire AE (1995) Alveolar cell hyperplasia in association with adenocarcinoma of the lung. Mod Pathol 8:165-169
26. Rosai J, Carangiu MI, DeLellis RA (1992) Tumors of the thyroid gland. Armed Forces Institute of Pathology, Washington, DC
27. Sasano H, Rojas M, Silverberg SG (1989) Analysis of lectin binding in benign and malignant thyroid nodules. Arch Pathol Lab Med 113:186-189
28. Schröder S, Schwarz W, Rehpenning W, Loning T, Böcker W (1987) Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland. Virchows Arch [A] 411:435-439
29. Schröder S, Schwarz W, Rehpenning W, et al (1988) Leu-M1 immunoreactivity and prognosis of medullary carcinomas of the thyroid gland. J Cancer Res Clin Oncol 114:291-296
30. Scopa CD, Melachrinou M, Saradopoulou C, Merino MJ (1993) The significance of the grooved nucleus in thyroid lesions. Mod Pathol 6:691-694
31. Sheibani K, Battifora H, Burke JS (1986) Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of LeuM1 antigen. Am J Pathol 123:212-219
32. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM (1992) Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 23: 107-116
33. Sobrinho-Simoes M (1995) Tumours of the thyroid: a brief overview with emphasis on the most controversial issues. Curr Diagn Pathol 2:15-22
34. Sobrinho-Simoes M, Damjanov I (1986) Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland. Arch Pathol Lab Med 110:722-729
35. Stanta G, Carangiu ML, Rosai J (1988) The biochemical and immunohistochemical profile of thyroid neoplasia. Pathol Annu 23:129-157
36. Stein H, Uchanska-Ziegler B, Gerdes J, Ziegler A, Wernet P (1982) Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer 29:283-290
37. Strickler JG, Herndier BG, Rouse RV (1987) Immunohistochemical staining in malignant mesotheliomas. Am J Clin Pathol 88:610-614
38. Vijayakumar T, Augustine J, Mathew L, et al (1992) Tissue binding pattern of plant lectins in benign and malignant lesions of thyroid. J Exp Pathol 6:11-23
39. Warnock ML, Stoloff A, Thor A (1988) Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1. Am J Pathol 133:30-38
40. Wick MR, Loy T, Mills SE, Legier JF, Manivel JC (1990) Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol 21:759-766
41. Xu XC, El-Naggar AK, Lotan R (1995) Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147:815-822